Haploidentical Transplantation Supported by Third-party Cord Blood vs Haploidentical Transplantation in Haematological Malignancies
Hematological Malignancies
Enrolment: 314 · Results not recorded
Loading the evidence…
Biologic
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Hematological Malignancies
Enrolment: 314 · Results not recorded
Leukemia · Myelodysplastic Syndromes
Enrolment: 16 · Results not recorded
Leukemia · Myelodysplastic Syndrome · Lymphoma
Enrolment: 84 · Results not recorded
Autism Spectrum Disorder
Enrolment: 30 · Results not recorded
Lymphoma · Myeloma · Leukemia · Myelodysplasia · Solid Tumors · Hodgkin's Disease · Myelofibrosis
Enrolment: 40 · Results not recorded
Sickle Cell Disease · Umbilical Cord Blood
Enrolment: 0 · Results not recorded
Severe Combined Immunodeficiency Syndrome
Enrolment: 8 · Results not recorded
Cord Blood Stem Cell Transplantation · Hematopoietic Stem Cell Transplantation
Enrolment: 250000 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Traumatic spinal cord injury
Transplantation on day one gave significantly higher BBB scores and differences in infarct size and blood vessel density compared with day six and control; transplanted cells survived at least three weeks but did not differentiate into neural cells.
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.